Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Individual results may vary
Disclosure of interest: FAM, KG, VR, MK, WNW, KB, PH have nothing to disclose Poster Session I - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.01 - PREVENTION P405 - ESOC25-1791 THE IMPACT OF FRAILTY ON STROKE RISK IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION Natalie Burgos Bencosme 1 , Sarah Rodrguez Santiago 1 , Lucia Antua Montes 1 , Elena Valle Calongue 1 , German Guzman Gutierrez 2 , Sara Fueyo lvarez 1 , Julieth Caballero Velsquez 1 , Eva Lopez Alvarez 1 , Jos Gutirrez Rodrguez 1 , Monserrat Gonzlez Delgado 3 , Jorge Herrera Parra 1 1 Monte Naranco Hospital, Oviedo, Spain, 2 University of Aberdeen-NHS Grampian, Aberdeen, United Kingdom, 3 Central University Hospital of Asturias, Oviedo, Spain Background and Aims: In the context of an ageing population, understanding how elderly individuals with atrial fibrillation (AF) characteristics influence stroke incidence is crucial
The duration and structure of these protocols are individualized by the physician based on the extent and nature of the surgical wound, the patient's baseline healing capacity (which correlates with age and plasma GHK levels), and clinical response during treatment
October 5, 2022
Is MUSE Cell Therapy Right for You
US$ 25.50
US$ 25.63
US$ 23.33
US$ 24.79
US$ 21.36